Cardiac and Pregnancy Outcomes of Pregnant Patients With Congenital Heart Disease According to Risk Classification System.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 12 2021
Historique:
received: 12 06 2021
revised: 19 08 2021
accepted: 23 08 2021
pubmed: 13 10 2021
medline: 1 12 2021
entrez: 12 10 2021
Statut: ppublish

Résumé

Pregnancy risk assessment for patients with adult congenital heart disease (ACHD) must include physiologic and anatomic impacts. We aimed to determine whether maternal cardiac and pregnancy outcomes vary by disease severity defined according to the following 3 different classifications: ACHD anatomic severity, ACHD physiologic class, and modified World Health Organization (mWHO) class. Cardiac outcomes included a composite of arrhythmia, heart failure, stroke, and thromboembolism. Pregnancy outcomes included a composite of intrauterine growth restriction, preterm birth, preeclampsia, or postpartum hemorrhage. We employed generalized estimating equations to account for multiple pregnancies. Of the 245 pregnancies, 17.1% were preterm and 45.7% were cesarean deliveries. Cardiac hospitalizations occurred in 22.0% and arrhythmias in 12.7%. Cardiac outcomes tended to be more prevalent in people with more severe heart disease. Pregnancy outcomes were U-shaped or less prevalent in people with more severe disease. There was a 2.9-fold increased risk for the composite cardiac outcome for complex anatomy (adjusted incidence rate ratio 2.90, 95% confidence interval 1.08 to 7.81, p = 0.04), a 9.4-fold increased risk for physiologic class C or D (9.37, 1.28 to 68.79, p = 0.03), and a fourfold increased risk for mWHO class III or IV (3.99, 1.53 to 10.40, p = 0.005). There was a lower risk for the composite pregnancy outcome for mWHO class II or II to III (0.54, 0.36 to 0.79, p = 0.002) but no association with anatomy or physiology. In conclusion, physiologic class may be most accurately associated with adverse outcomes and therefore efforts to optimize hemodynamics before pregnancy may help to mitigate the risk.

Identifiants

pubmed: 34635313
pii: S0002-9149(21)00821-3
doi: 10.1016/j.amjcard.2021.08.037
pmc: PMC10686784
mid: NIHMS1943868
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-101

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors have no conflicts of interest to disclose.

Références

Congenit Heart Dis. 2019 May;14(3):470-478
pubmed: 30729681
Am J Cardiol. 2006 Apr 15;97(8):1206-12
pubmed: 16616027
Heart. 2014 Sep;100(17):1373-81
pubmed: 25034822
JAMA Cardiol. 2017 Jun 1;2(6):664-671
pubmed: 28403428
J Am Coll Cardiol. 2018 May 29;71(21):2419-2430
pubmed: 29793631
J Am Coll Cardiol. 2021 Apr 13;77(14):1763-1777
pubmed: 33832604
Eur Heart J. 2018 Sep 7;39(34):3165-3241
pubmed: 30165544
Circulation. 2020 Jun 9;141(23):e884-e903
pubmed: 32362133
JAMA Netw Open. 2019 May 3;2(5):e193667
pubmed: 31074818
J Am Coll Cardiol. 2021 Apr 13;77(14):1778-1798
pubmed: 33832605
Obstet Med. 2017 Jun;10(2):53-57
pubmed: 28680462
J Am Coll Cardiol. 2021 Apr 13;77(14):1813-1822
pubmed: 33832607
J Am Coll Cardiol. 2019 May 7;73(17):2181-2191
pubmed: 31047006
Circulation. 2019 Apr 2;139(14):e698-e800
pubmed: 30586767

Auteurs

Jill M Steiner (JM)

Division of Cardiology. Electronic address: jills8@uw.edu.

Erica Lokken (E)

Department of Obstetrics and Gynecology; Department of Global Health, University of Washington, Seattle, Washington.

Elizabeth Bayley (E)

Division of Cardiology.

Jaimie Pechan (J)

Division of Cardiology.

Anna Curtin (A)

Department of Obstetrics and Gynecology.

Jonathan Buber (J)

Division of Cardiology.

Catherine Albright (C)

Department of Obstetrics and Gynecology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH